Linneo Health Expands Medicinal Cannabis Offering With Industrial Cannabis Derivatives

Linneo Health has expanded its medicinal offering to include industrial derivatives. This follows the issuance of good manufacturing practice (EU-GMP) certification for the industrial processing of derivatives to Alcaliber, by the Spanish Agency of Medicines and Medical Products.

Under the terms of an exclusive CDMO agreement with Alcaliber, Linneo Health now adds the capabilities to supply APIs and medicinal finished dosage forms, such as THC and standardized extracts, in addition to its existing EU-GMP certified medicinal cannabis flowers.

Don Bellamy, …

Full story available on Benzinga.com

Linneo Health Expands Medicinal Cannabis Offering With Industrial Cannabis Derivatives on Benzinga